|
Latest texts and monographs on
Nasal Polyps Recent Patents, and PUBMED / MEDLINE research entries. Living with Chronic Sinusitis: A Patient's Guide to Sinusitis, Nasal Allegies, Polyps and their Treatment Options by David W. Kennedy Nasal Polyps: Epidemiology, Pathogenesis and Treatment by Guy A. Settipane Recent Nasal Polyps related patents From USPTO: Are you interested in Feng Shui? 6715485: Nasal delivery device 6693077: Keratinocyte growth factor-2 6689803: Compositions and methods for treating surgical adhesions 6688497: Apparatus and method for tissue rinse 6686346: Formulation 6673549: Genes expressed in C3A liver cell cultures treated with steroids 6670389: Laulimalide derivatives 6669059: System and method for passage rinse 6659106: System and methods for electrosurgical treatment of turbinates 6656966: Nitrosated and nitrosylated taxanes, compositions and methods of use 6656946: Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases 6644305: Nasal inhaler 6642008: Assays and therapies for latent viral infection 6638218: System and method for delivering medical examination, diagnosis, and treatment over a network 6630483: Phenanthridine-N-oxides 6627634: Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them 6617329: Aminoquinazolines and their use as medicaments 6613794: Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation 6602890: Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation 6599927: Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome 6599719: Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha 6555566: Methods and materials for treating and preventing inflammation of mucosal tissue 6545158: Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation 6545025: Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation 6544993: Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors 6541623: Interleukin--1 receptor antagonist and uses thereof 6538005: Phenanthridine-N-oxides with PDE-IV inhibiting activity 6537983: Anti-inflammatory androstane derivatives 6534519: Phenanthridine-N-oxides with PDE-IV inhibiting activity 6534518: Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity 6520384: Apparatus and method for nasal rinse 6515016: Composition and methods of paclitaxel for treating psoriasis 6503953: Methods for treating atopic disorders 6495579: Method for treating multiple sclerosis 6492377: Imidazotriazolopyrimidines with adenosine-antagonistic activity 6492334: Tri-compound analgesic for treating inflammation and pain 6479505: 6-arylphenanthridines with PDE-IV inhibiting activity 6476025: Phenylphennanthridines with PDE-IV inhibiting activity 6472401: Methods for the treatment of vascular disorders 6465205: In vitro cell culture device including cartilage and methods of using the same 6436952: Benzonaphthyridine-N-oxides comprising a PDE3 and PDE4 inhibiting activity 6419687: Noseform, cover and rest-structure and method 6410551: Tetrazole derivatives 6403580: Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing them 6385611: System and method for database retrieval, indexing and statistical analysis 6384047: Benzonaphthyridine 6380222: Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps 6380196: Dihydrobenzofurans 6376485: Benzoxazoles with PDE-inhibiting activity from PUBMED 1: Tang J, Li Y. [Effect of erythromycin on the expression of apoptotic gene on eosinophils in nasal polyps in vitro] Zhonghua Er Bi Yan Hou Ke Za Zhi. 2003 Dec;38(6):451-4. Chinese. PMID: 15040110 2: Ragab A, Clement P, Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol. 2004 Jan-Feb;18(1):15-21. PMID: 15035566 3: Rane S, Jayaraman A, Holla VV. Allergic fungal rhinosinusitis--a case report. Indian J Pathol Microbiol. 2003 Jul;46(3):450-1. PMID: 15025301 4: Rudack C, Sachse F, Alberty J. Chronic rhinosinusitis--need for further classification? Inflamm Res. 2004 Mar;53(3):111-7. Epub 2004 Feb 16. PMID: 15021966 5: Chen J, Xiang J. [Expression of NO and NOS in nasal polyps] Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003 Dec;17(12):742-4. Chinese. PMID: 15017725 6: Ozcan C, Zeren H, Talas DU, Kucukoglu M, Gorur K. Antrochoanal polyp: a transmission electron and light microscopic study. Eur Arch Otorhinolaryngol. 2004 Mar 5 [Epub ahead of print] PMID: 15004706 [PubMed - as supplied by publisher] 7: Montier T, Delepine P, Marianowski R, Le Ny K, Le Bris M, Gillet D, Potard G, Mondine P, Frachon I, Yaouanc JJ, Clement JC, Des Abbayes H, Ferec C. CFTR Transgene Expression in Primary DeltaF508 Epithelial Cell Cultures From Human Nasal Polyps Following Gene Transfer With Cationic Phosphonolipids. Mol Biotechnol. 2004 Mar;26(3):193-206. PMID: 15004288 8: Johansson L, Bramerson A, Holmberg K, Melen I, Akerlund A, Bende M. Clinical relevance of nasal polyps in individuals recruited from a general population-based study. Acta Otolaryngol. 2004 Jan;124(1):77-81. PMID: 14977082 9: Rodrigo JP, Garcia-Pedrero JM, Gonzalez MV, Fernandez MP, Suarez C, Herrero A. Expression of annexin A1 in normal and chronically inflamed nasal mucosa. Arch Otolaryngol Head Neck Surg. 2004 Feb;130(2):211-5. PMID: 14967753 10: Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A, Osame M, Akiyama K. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2004 Feb;113(2):277-83. PMID: 14767442 11: Okano M. [Pathophysiology and treatment of intractable sinusitis] Arerugi. 2004 Jan;53(1):1-7. Japanese. PMID: 14762324 12: Bernstein JM, Ballow M, Schlievert PM, Rich G, Allen C, Dryja D. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol. 2003 Nov-Dec;17(6):321-6. PMID: 14750606 13: Jornot L, Rochat T, Lacroix JS. Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. Rhinology. 2003 Dec;41(4):201-5. PMID: 14750346 14: Dahl M, Schaffer S, Wisdom GS. Inverting papilloma of the nose and paranasal sinuses. J La State Med Soc. 2003 Sep-Oct;155(5):235-7. PMID: 14748483 15: Zhang X, Yuan YY, Gu WP, Mu JS, Qu Y, Gao HT. [Expression and distribution of aquaporin-2 in nasal polyps] Zhonghua Er Bi Yan Hou Ke Za Zhi. 2003 Aug;38(4):272-4. Chinese. PMID: 14743636 16: Zhou B, Han DM, Liu HC, Liu M, Huang Q, Zhang L, Wang JL, Zhang YJ. [Long-term outcomes and analysis of its relative factors of nasal endoscopic sinus surgery in children] Zhonghua Er Bi Yan Hou Ke Za Zhi. 2003 Aug;38(4):255-8. Chinese. PMID: 14743632 17: Wicherek L, Dutsch M, Mak P, Klimek M, Skladzien J, Dubin A. Comparative analysis of RCAS1 level in neoplasmsand placenta. Acta Biochim Pol. 2003;50(4):1187-94. PMID: 14740005 18: Bonfils P, Nores JM, Malinvaud D, Bozec H, Avan P. [Adrenal insufficiency after treatment of nasal polyposis] Ann Otolaryngol Chir Cervicofac. 2003 Dec;120(6):338-42. French. PMID: 14730278 19: Wang X, Yin J, Zhai S. [Factors that affect the improvement of olfactory function after endoscopic sinus surgery in patients suffering from chronic sinusitis and/or nasal polyps] Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003 Oct;17(10):609-11. Chinese. PMID: 14727434 20: Prades JM, Chelikh L, Dumollard JM, Merzougui N, Timoshenko A, Martin Ch. [Nasal polyposis: quantification of the eosinophil and granulocyte infiltrates. Anatomo-clinical correlations] Ann Otolaryngol Chir Cervicofac. 2003 Nov;120(5):279-85. French. PMID: 14726847 |